Mizuho Downgrades Kura Oncology to Outperform, PT Lowered to $25.

Tuesday, Mar 24, 2026 1:16 pm ET1min read
KURA--

Mizuho Downgrades Kura Oncology to Outperform, PT Lowered to $25.

Mizuho Downgrades Kura Oncology to Outperform, PT Lowered to $25.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet